Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: Is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?

Stroke

Volumn 33, Issue 6, 2002, Pages 1723-1726

  Hankey, Graeme J ^a   Fisher, Marc ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Anticoagulants; Aspirin; Clinical trials; Stroke, ischemic

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ANTICOAGULATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; STROKE; TREATMENT OUTCOME;

ANTICOAGULANTS; ASPIRIN; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DATA INTERPRETATION, STATISTICAL; EMBOLISM; ENDPOINT DETERMINATION; HUMANS; ODDS RATIO; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; RECURRENCE; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; WARFARIN;

EID: 0036278194     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000016922.22707.27     Document Type: Review

References (12)

1. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke
2. Cumulative meta-analysis of aspirin efficacy after cerebral ischaemia of arterial origin
3. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
4. Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack (Cochrane Review)
5. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin (Cochrane Review)
6. Design of ESPRIT: An international randomised trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin
7. Management of intracranial arterial stenosis in a heterogeneous population
8. Best treatment for intracranial arterial stenosis?: 50 years of uncertainty
9. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
10. Oral anticoagulation for cerebral ischemia of presumed arterial origin. High initial bleeding risk
11. Placebo-controlled trials and active-control trials in the evaluation of new treatments, 1: Ethical and scientific issues
12. Baseline frequencies, isotypes, and titers of antiphospholipid antibodies in the Warfarin Aspirin Recurrent Stroke Study/Antiphospholipid Antibody Study (WARSS/ APASS) collaboration: Preliminary results